𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Wide gene expression profiling of ischemia-reperfusion injury in human liver transplantation

✍ Scribed by Anna Conti; Simona Scala; Paola D'Agostino; Elena Alimenti; Daniele Morelli; Barbara Andria; Angela Tammaro; Chiara Attanasio; Floriana Della Ragione; Vincenzo Scuderi; Floriana Fabbrini; Maurizio D'Esposito; Ernesto Di Florio; Lucio Nitsch; Fulvio Calise; Antonio Faiella


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
301 KB
Volume
13
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

✦ Synopsis


Ischemia-reperfusion injury (IRI) causes up to 10% of early liver failures in humans and can lead to a higher incidence of acute and chronic rejection. So far, very few studies have investigated wide gene expression profiles associated with the IRI process. The discovery of novel genes activated by IRI might lead to the identification of potential target genes for the prevention or treatment of the injury. In our study, we compared gene expression levels in reperfused livers (RL group) vs. the basal values before retrieval from the donor (basal liver [BL] group) using oligonucleotide array technology. We examined 10 biopsies from 5 livers, analyzing approximately 33,000 genes represented on the Affymetrix HG-U133APlus 2.0 oligonucleotide arrays (Affymetrix, Santa Clara, CA). About 13,000 individual genes were considered expressed in at least 1 condition. A total of 795 genes whose expression is significantly modified by ischemia-reperfusion in human liver transplantation were identified in this study. Some of them are likely to be completely activated by IRI, as they are not expressed in basal livers. The supervised gene expression analysis revealed that at least 12% of the genes involved in the apoptotic process, 12.5% of the genes involved in inflammatory processes, and 22.5% of the genes encoding for heat shock proteins are differentially expressed in RL samples vs. BL samples. Furthermore, IRI induces the upregulation of some genes' coding for adhesion molecules and integrins. In conclusion, we have identified a relevant amount of early genes regulated in the human liver after 7-9 hours of cold ischemia and 2 hours from reperfusion, many of them not having been described before in this process. Their analyses may help us to better understand the pathophysiology of IRI and to characterize potential target genes for the prevention or treatment of the liver injury in order to increase the number of patients that successfully undergo transplantation.


πŸ“œ SIMILAR VOLUMES


Global gene expression profiles of ische
✍ Ali Raza; George Dikdan; Kunj K. Desai; Asif Shareef; Helen Fernandes; Virginie πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 326 KB πŸ‘ 2 views

The benefits of ischemic preconditioning (IPC) in reducing ischemia/reperfusion injury (IRI) remain indistinct in human liver transplantation (LT). To further understand mechanistic aspects of IPC, we performed microarray analyses as a nested substudy in a randomized trial of 10-minute IPC in 101 de

Expression profiles of genes associated
✍ M. Nakamuta; T. Fujino; R. Yada; Y. Aoyagi; K. Yasutake; M. Kohjima; K. Fukuizum πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 406 KB πŸ‘ 1 views

## Abstract Recent studies have demonstrated that several cellular factors are involved in entry of hepatitis C virus (HCV) into host cells. Detailed gene expression profiles of these factors in HCV‐infected livers have not been reported for humans. Transcriptional levels of LDL receptor (LDLR), CD

Microarray analysis of acute and delayed
✍ X.-C. May Lu; Anthony J. Williams; Changping Yao; Rossana Berti; Jed A. Hartings πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 238 KB πŸ‘ 1 views

## Abstract Temporal changes in gene expression were measured using DNA microarrays after 30‐min or 2‐hr transient middle cerebral artery occlusion (MCAo) in rats. Total RNA was extracted from the injured hemisphere at 30 min, 4 hr, 8 hr, 24 hr, 3 days, and 7 days after MCAo for GeneChip analysis u